Human serum RNase-L level is inversely associated with metabolic syndrome and age

Table 3 The relations among serum RNase-L, metabolic factors, and treatments in multivariate linear regression analyses

Variables	Model 1 β (SE) P value	Model 2	Model 3	Model 4	Model 5	Model 6	Model 7
Age (year)	−0.090 (0.041)	−0.099 (0.041)	−0.111 (0.041)	−0.097(0.041)	−0.092 (0.041)	−0.114 (0.041)	−0.111 (0.041)
Age (year)	0.080	0.053	0.032	0.060	0.073	0.026	0.031
Gender (% male)	−0.023 (0.788)	−0.025 (0.789)	−0.036 (0.788)	0.016 (0.821)	0.006 (0.824)	0.043 (0.864)	−0.004 (0.809)
Gender (% male)	0.655	0.621	0.477	0.761	0.903	0.439	0.933
Hypertension treatment (%)	−0.121 (0.976)			−0.076 (1.029)	−0.087 (1.035)
Hypertension treatment (%)	0.020			0.162	0.114
Hyperlipidemia treatment (%)		−0.107 (1.221)				−0.102 (1.210)	−0.096 (1.227)
Hyperlipidemia treatment (%)		0.038				0.046	0.063
DM treatment (%)			−0.040 (1.417)
DM treatment (%)			0.442
Diastolic blood pressure (mmHg)				−0.137 (0.038)
Diastolic blood pressure (mmHg)				0.014
Mean arterial pressure (mmHg)					−0.103 (0.036)
Mean arterial pressure (mmHg)					0.067
HDL-C (mg/dl)						0.157 (0.032)
HDL-C (mg/dl)						0.004
Triglyceride (mg/dl)							−0.089 (0.004)
Triglyceride (mg/dl)							0.088

The β (SE) and the P value for each factor in the models are shown, and the P values shown in italics text are significant (P < 0.05)

ISSN: 1475-2840